We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC’s Silence Threatens GPhA Third-Party Shortages Plan
FTC’s Silence Threatens GPhA Third-Party Shortages Plan
June 27, 2012
The Federal Trade Commission (FTC) may not issue the advisory opinion the generic drug industry is waiting for before launching its third-party drug shortage program, possibly derailing the initiative.